A comparative study between Fc receptor bearing cells and antibody dependent cell cytotoxicity in cancer patients. 1980

F Gutiérrez, and E Sánchez-Cantalejo, and E Garcia-Olivares, and F Garrido, and C Osorio

The capacity of 14 cancer patients lymphoid cells to destroy antibody-coated target cells (antibody-dependent cell cytotoxicity ADCC), and to form rosettes with immunoglobulin-coated erythrocytes (EA) was compared. The lymphocyte functions were investigated immediately prior to chemo-immunotherapy. Our observations show a correlation between the percentage of EA-rosette forming cells and ADCC activity of cancer patients and controls. However, the regressive lines were different in both groups. Interestingly, cancer patients with a lower. EA rosette forming cells than controls, showed higher cytotoxic activity.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011961 Receptors, Fc Molecules found on the surface of some, but not all, B-lymphocytes, T-lymphocytes, and macrophages, which recognize and combine with the Fc (crystallizable) portion of immunoglobulin molecules. Fc Receptors,Fc Receptor,Receptor, Fc
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000920 Antibody-Dependent Cell Cytotoxicity The phenomenon of antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IMMUNOGLOBULIN G whose Fc portion is intact. The effector cell is a "killer" cell possessing Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent. ADCC,Cytotoxicity, Antibody-Dependent Cell,Cell Cytoxicity, Antibody-Dependent,Antibody Dependent Cell Cytotoxicity,Antibody-Dependent Cell Cytotoxicities,Antibody-Dependent Cell Cytoxicities,Antibody-Dependent Cell Cytoxicity,Cell Cytotoxicities, Antibody-Dependent,Cell Cytotoxicity, Antibody-Dependent,Cell Cytoxicities, Antibody-Dependent,Cell Cytoxicity, Antibody Dependent,Cytotoxicities, Antibody-Dependent Cell,Cytotoxicity, Antibody Dependent Cell,Cytoxicities, Antibody-Dependent Cell,Cytoxicity, Antibody-Dependent Cell
D012397 Rosette Formation The in vitro formation of clusters consisting of a cell (usually a lymphocyte) surrounded by antigenic cells or antigen-bearing particles (usually erythrocytes, which may or may not be coated with antibody or antibody and complement). The rosette-forming cell may be an antibody-forming cell, a memory cell, a T-cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells. Immunocytoadherence,Formation, Rosette,Formations, Rosette,Immunocytoadherences,Rosette Formations

Related Publications

F Gutiérrez, and E Sánchez-Cantalejo, and E Garcia-Olivares, and F Garrido, and C Osorio
July 1980, Journal of immunology (Baltimore, Md. : 1950),
F Gutiérrez, and E Sánchez-Cantalejo, and E Garcia-Olivares, and F Garrido, and C Osorio
June 1977, Journal of immunology (Baltimore, Md. : 1950),
F Gutiérrez, and E Sánchez-Cantalejo, and E Garcia-Olivares, and F Garrido, and C Osorio
January 1974, International archives of allergy and applied immunology,
F Gutiérrez, and E Sánchez-Cantalejo, and E Garcia-Olivares, and F Garrido, and C Osorio
January 1982, Journal of cancer research and clinical oncology,
F Gutiérrez, and E Sánchez-Cantalejo, and E Garcia-Olivares, and F Garrido, and C Osorio
May 1983, Cellular immunology,
F Gutiérrez, and E Sánchez-Cantalejo, and E Garcia-Olivares, and F Garrido, and C Osorio
December 1983, Hinyokika kiyo. Acta urologica Japonica,
F Gutiérrez, and E Sánchez-Cantalejo, and E Garcia-Olivares, and F Garrido, and C Osorio
December 1991, Journal of virology,
F Gutiérrez, and E Sánchez-Cantalejo, and E Garcia-Olivares, and F Garrido, and C Osorio
January 1978, Scandinavian journal of immunology,
Copied contents to your clipboard!